A safe and effective vaccine candidate is urgently needed for the ongoing COVID-19 pandemic, caused by SARS-CoV-2. Here we report that recombinant SARS-CoV-2 RBD protein immunization in mice is able to elicit a strong antibody response and potent neutralizing capability as measured using live or pseudotyped SARS-CoV-2 neutralization assays.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993121 | PMC |
| http://dx.doi.org/10.1080/21645515.2020.1814098 | DOI Listing |
Publication Analysis
Top Keywords
antibody response
8
neutralizing antibody
4
response elicited
4
sars-cov-2
4
elicited sars-cov-2
4
sars-cov-2 receptor-binding
4
receptor-binding domain
4
domain safe
4
safe effective
4
effective vaccine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!